Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo - PubMed (original) (raw)

Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo

B J Mayer et al. Mol Cell Biol. 1992 Feb.

Abstract

We have constructed a series of point mutations in the highly conserved FLVRES motif of the src homology 2 (SH2) domain of the abl tyrosine kinase. Mutant SH2 domains were expressed in bacteria, and their ability to bind to tyrosine-phosphorylated proteins was examined in vitro. Three mutants were greatly reduced in their ability to bind both phosphotyrosine itself and tyrosine-phosphorylated cellular proteins. All of the mutants that retained activity bound to the same set of tyrosine-phosphorylated proteins as did the wild type, suggesting that binding specificity was unaffected. These results implicate the FLVRES motif in direct binding to phosphotyrosine. When the mutant SH2 domains were inserted into an activated abl kinase and expressed in murine fibroblasts, decreased in vitro phosphotyrosine binding correlated with decreased transforming ability. This finding implies that SH2-phosphotyrosine interactions are involved in transmission of positive growth signals by the nonreceptor tyrosine kinases, most likely via the assembly of multiprotein complexes with other tyrosine-phosphorylated proteins.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1991 Jan 25;64(2):281-302 - PubMed
    1. Science. 1990 Jun 22;248(4962):1537-9 - PubMed
    1. J Virol. 1990 Aug;64(8):3581-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8592-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8622-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources